Detalles de la búsqueda
1.
Regulatory T-cells activated in metastatic draining lymph nodes possibly suppress cancer immunity in cancer tissues of head and neck squamous cell cancer.
Pathol Int
; 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38712798
2.
A novel mouse model of cutaneous T-cell lymphoma revealed the combined effect of mogamulizumab with psoralen and ultraviolet a therapy.
Exp Dermatol
; 31(11): 1693-1698, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35801380
3.
The dual pocket binding novel tankyrase inhibitor K-476 enhances the efficacy of immune checkpoint inhibitor by attracting CD8+ T cells to tumors.
Am J Cancer Res
; 11(1): 264-276, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33520373
4.
Robust CD8+ T-cell proliferation and diversification after mogamulizumab in patients with adult T-cell leukemia-lymphoma.
Blood Adv
; 4(10): 2180-2191, 2020 05 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32433748
5.
Expression of the ULBP ligands for NKG2D by B-NHL cells plays an important role in determining their susceptibility to rituximab-induced ADCC.
Int J Cancer
; 125(1): 212-21, 2009 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19358282
6.
In vivo activation of PEGylated long circulating lipid nanoparticle to achieve efficient siRNA delivery and target gene knock down in solid tumors.
J Control Release
; 311-312: 245-256, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31505222
7.
Mogamulizumab Treatment Elicits Autoantibodies Attacking the Skin in Patients with Adult T-Cell Leukemia-Lymphoma.
Clin Cancer Res
; 25(14): 4388-4399, 2019 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31018922
8.
Defucosylated anti CC chemokine receptor 4 monoclonal antibody combined with immunomodulatory cytokines: a novel immunotherapy for aggressive/refractory Mycosis fungoides and Sezary syndrome.
Clin Cancer Res
; 13(21): 6494-500, 2007 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17975162
9.
Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege.
Cancer Res
; 66(11): 5716-22, 2006 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16740709
10.
An anti-ASCT2 monoclonal antibody suppresses gastric cancer growth by inducing oxidative stress and antibody dependent cellular toxicity in preclinical models.
Am J Cancer Res
; 8(8): 1499-1513, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30210919
11.
Clinical significance of a blood eosinophilia in adult T-cell leukemia/lymphoma: a blood eosinophilia is a significant unfavorable prognostic factor.
Leuk Res
; 31(7): 915-20, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17123603
12.
Potent Therapeutic Activity Against Peritoneal Dissemination and Malignant Ascites by the Novel Anti-Folate Receptor Alpha Antibody KHK2805.
Transl Oncol
; 10(5): 707-718, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28710915
13.
Anti-tumor efficacy evaluation of a novel monoclonal antibody targeting neutral amino acid transporter ASCT2 using patient-derived xenograft mouse models of gastric cancer.
Am J Transl Res
; 9(7): 3399-3410, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28804556
14.
A neutralizing anti-fibroblast growth factor 8 monoclonal antibody shows potent antitumor activity against androgen-dependent mouse mammary tumors in vivo.
Clin Cancer Res
; 11(10): 3897-904, 2005 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15897591
15.
The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-Cell leukemia/lymphoma.
Clin Cancer Res
; 10(22): 7529-39, 2004 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15569983
16.
[Anti-CCR4 monoclonal antibody as a novel therapy for advanced mycosis fungoides and Sézary syndrome].
Rinsho Ketsueki
; 50(12): 1671-8, 2009 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-20068273
17.
Augmentation of antitumour activity of defucosylated chimeric anti-CCR4 monoclonal antibody in SCID mouse model of adult T-cell leukaemia/lymphoma using G-CSF.
Br J Haematol
; 140(5): 586-9, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18205860
18.
New molecular and biological mechanism of antitumor activities of KW-2478, a novel nonansamycin heat shock protein 90 inhibitor, in multiple myeloma cells.
Clin Cancer Res
; 16(10): 2792-802, 2010 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20406843
19.
Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia/lymphoma.
Clin Cancer Res
; 16(5): 1520-31, 2010 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20160057
20.
[Development of an anti-CCR4 antibody, mogamulizumab, the first approved antibody made by POTELLIGENT(®) technology].
Nihon Yakurigaku Zasshi
; 142(4): 167-71, 2013 Oct.
Artículo
en Japonés
| MEDLINE | ID: mdl-24107520